0000899243-19-007526.txt : 20190313
0000899243-19-007526.hdr.sgml : 20190313
20190313161024
ACCESSION NUMBER: 0000899243-19-007526
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190311
FILED AS OF DATE: 20190313
DATE AS OF CHANGE: 20190313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Orford Keith
CENTRAL INDEX KEY: 0001670740
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36644
FILM NUMBER: 19678352
MAIL ADDRESS:
STREET 1: CALITHERA BIOSCIENCES
STREET 2: 343 OYSTER POINT BLVD, SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Calithera Biosciences, Inc.
CENTRAL INDEX KEY: 0001496671
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272366329
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 343 OYSTER POINT BLVD #200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-870-1000
MAIL ADDRESS:
STREET 1: 343 OYSTER POINT BLVD #200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-11
0
0001496671
Calithera Biosciences, Inc.
CALA
0001670740
Orford Keith
C/O CALITHERA BIOSCIENCES, INC.
343 OYSTER POINT BLVD. #200
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
Common Stock
2019-03-11
4
S
0
1565
6.00
D
11249
D
Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on April 25, 2018.
Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 10, 2018.
/s/ Keith Orford
2019-03-13